Graft Failure Clinical Trials

51 clinical trials for Graft Failure across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Differences in Outcomes and Failure Rates Between Allografts and Autografts in Revision Anterior Cruciate Ligament Reconstruction — RECRUITING
• Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease — RECRUITING · PHASE1
• Allo HSCT for High Risk Hemoglobinopathies — RECRUITING · PHASE2
• Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery — RECRUITING
• Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients — RECRUITING · PHASE1
• Pilot Trial of Colchicine for Graft Failure in CABG — RECRUITING · PHASE4
• One-year Patency Comparison Between Radial Artery and No-touch Saphenous Vein Grafts in Women Undergoing Isolated CABG — RECRUITING · NA
• CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure — RECRUITING · NA
• Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection — RECRUITING
• Modified Second Haplo-transplantation for Graft Failure — RECRUITING · NA
• Second Haplo-transplantation for Graft Failure — RECRUITING · NA
• Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure — RECRUITING · PHASE4
• Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease — RECRUITING
• Tumescence in HNC Skin Graft Reconstruction — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy — COMPLETED · PHASE2
• Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients — COMPLETED
• Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen — COMPLETED · PHASE2
• RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation — TERMINATED · PHASE2
• Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABG — WITHDRAWN · PHASE4
• Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients — COMPLETED
• Factors for Impairment of Renal Graft Function in Intensive Care — OTHER
• Study of the No-touch Saphenous Vein Graft — OTHER · NA
• Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT. — TERMINATED · PHASE2
• Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis — NOT_YET_RECRUITING · PHASE1
• A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant — TERMINATED
• Semitendinosus Graft as Meniscal Transplant — OTHER
• Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure — NOT_YET_RECRUITING · PHASE2
• Glycerin-Preserved, Human-Donor, Corneoscleral Patch Grafts for Glaucoma Drainage Devices — COMPLETED
• Intraoperative NIRS of Transplanted Kidney for Prediction of Acute and Sub-acute Injury — OTHER · PHASE3
• Second Transplantation for Graft Failure — OTHER · NA
• Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East — COMPLETED
• Clinical Effect of No-touch Harvesting Technique in OPCABG — OTHER · NA
• Deceased Donor Biomarkers and Recipient Outcomes — COMPLETED
• Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H — TERMINATED · PHASE1
• Immunization Anti HLA in the Liver Transplant Recipients (DSATH) — OTHER · NA
• Arthroscopic Superior Capsular Reconstruction With Fascia Lata Autograft - Survivorship of the Autograft Analysis — COMPLETED · NA
• Silver Graft All Comers Registry — COMPLETED
• A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients — OTHER · PHASE2
• Early Silent Graft Failure in Off-pump Coronary Artery Bypass Grafting: A Computed Tomography Analysis — COMPLETED
• TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study — ACTIVE_NOT_RECRUITING
• TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion — TERMINATED · PHASE2
• CliniMACS® CD34+ Reagent System for Expanded Access Use — TERMINATED
• European Transplant Registry of Senior Renal Transplant Recipients on Advagraf — NOT_YET_RECRUITING
• Renal Transplantation in the Elderly - nEverOld Study — OTHER · PHASE4
• Induction of HO-1; a Therapeutic Approach to Reduce Ischaemia Reperfusion Injury (IRI) Following Deceased Donor Renal Transplantation — COMPLETED · PHASE3
• EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs — OTHER · PHASE1
• Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant — OTHER · PHASE2
• Patency-Coronary Trial — OTHER · NA
• Terminal Graft Failure — TERMINATED
• Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation — COMPLETED · PHASE1

Refine this search